Bernstein on Gilead Sciences (GILD) Amid Ouro Acquisition
March 24, 2026 8:13 AM
Bernstein SocGen Group analyst Courtney Breen reiterated an Outperform rating and $160.00 price target on Gilead Sciences (NASDAQ: GILD).The analyst ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
